1. Jones A, Jarvis P. Review of the potential use of blood neuro-biomarkers in the diagnosis of mild traumatic brain injury. Clin. Exp. Emerg. Med. 2017;4:121–7. https://www.ncbi.nlm.nih.gov/pubmed/29026884
2. O’Neil ME, Carlson K, Storzbach D, Brenner L, Freeman M, Quiñones A, et al. Complications of Mild Traumatic Brain Injury in Veterans and Military Personnel: A Systematic Review. Washington (DC): Department of Veterans Affairs (US); 2013. http://www.ncbi.nlm.nih.gov/books/NBK189785/
3. Agoston DV, Shutes-David A, Peskind ER. Biofluid biomarkers of traumatic brain injury. Brain Inj. 2017;31:1195–203. https://www.ncbi.nlm.nih.gov/pubmed/28981341
4. Borg K, Bonomo J, Jauch EC, Kupchak P, Stanton EB, Sawadsky B. Serum Levels of Biochemical Markers of Traumatic Brain Injury. ISRN Emerg. Med. 2012;2012:1–7. https://www.hindawi.com/journals/isrn/2012/417313
5. Yokobori S, Hosein K, Burks S, Sharma I, Gajavelli S, Bullock R. Biomarkers for the clinical differential diagnosis in traumatic brain injury--a systematic review. CNS Neurosci Ther. 2013 Aug;19(8):556-65. doi: 10.1111/cns.12127.
6. Sapin V, Gaulmin R, Aubin R, Walrand S, Coste A, Abbot M. Blood biomarkers of mild traumatic brain injury: State of art. Neurochirurgie. 2021 May;67(3):249-254. doi: 10.1016/j.neuchi.2021.01.001.
7. Welch RD, Ayaz SI, Lewis LM, Unden J, Chen JY, Mika VH, et al. Ability of serum glial fibrillary acidic protein, ubiquitin C-terminal hydrolase-L1, and S100B to differentiate normal and abnormal head computed tomography findings in patients with suspected mild or moderate traumatic brain injury. J Neu- rotrauma 2016;33(2):203–14.
8. Unden L, Calcagnile O, Unden J, Reinstrup P, Bazarian J. Validation of the Scan- dinavian guidelines for initial management of minimal, mild and moderate traumatic brain injury in adults. BMC Med 2015;13:292
9. Kawata K, Liu CY, Merkel SF, et al. Blood biomarkers for brain injury: What are we measuring? Neurosci Biobehav Rev. 2016 Sep; 68: 460–473. doi: 10.1016/j.neubiorev.2016.05.009
10. Michetti F, D'Ambrosi N, Toesca A, Puglisi MA, Serrano A, Marchese E, Corvino V, Geloso MC. The S100B story: from biomarker to active factor in neural injury. J Neurochem. 2019 Jan;148(2):168-187. doi: 10.1111/jnc.14574.
11. Hiskens MI, Schneiders AG, Angoa-Pérez M,et al. Blood biomarkers for assessment of mild traumatic brain injury and chronic traumatic encephalopathy. Biomarkers. 2020 May;25(3):213-227. doi: 10.1080/1354750X.2020.1735521.
12. Berger RP, Hayes RL, Richichi R, Beers SR, Wang KKW. Serum concentrations of ubiquitin C-terminal hydrolase-L1 and alphaII-spectrin breakdown product 145kDa correlate with outcome after pediatric TBI. J Neurotrauma 2012;29(1):162–7.
13. Venkatramani A, Panda D. Regulation of neuronal microtubule dynamics by tau: implications for tauopathies. Int J Biol Macromol 2019;133:473–83.
14. Cardali S, Maugeri R. Detection of alphaII-spectrin and breakdown products in humans after severe traumatic brain injury. J. Neurosurg. Sci. 2006;50:25–31. https://www.ncbi.nlm.nih.gov/pubmed/16841024
15. Zemlan FP, Jauch EC, Mulchahey JJ, Gabbita SP, Rosenberg WS, Speciale SG, et al. C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome. Brain Res. 2002;947:131–9. https://www.ncbi.nlm.nih.gov/pubmed/12144861
16. Papa L, Lewis LM, Silvestri S, Falk JL, Giordano P, Brophy GM, et al. Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention. J. Trauma Acute Care Surg. 2012;72:1335–44. https://www.ncbi.nlm.nih.gov/pubmed/22673263
17. Papa, L, et al. Time Course and Diagnostic Accuracy of Glial and Neuronal Blood Biomarkers GFAP and UCH-L1 in a Large Cohort of Trauma Patients With and Without Mild Traumatic Brain Injury. JAMA Neurol. 2016;73(5): 551-560
18. Wąsik N, Sokół B, Hołysz M, Mańko W, et al. Serum myelin basic protein as a marker of brain injury in aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien). 2020 Mar;162(3):545-552. doi: 10.1007/s00701-019-04185-9.
19. Zetterberg H, Blennow K. Fluid biomarkers for mild traumatic brain injury and related conditions. Nat Rev Neurol. 2016 Oct;12(10):563-74. doi: 10.1038/nrneurol.2016.127.
20. Rubin LH, Tierney R, Kawata K, et al. NFL blood levels are moderated by subconcussive impacts in a cohort of college football players. Brain Inj. 2019;33(4):456-462. doi: 10.1080/02699052.2019.1565895.
21. Bogoslovsky T, Gill J, Jeromin A, Davis C, Diaz-Arrastia R. Fluid Biomarkers of Traumatic Brain Injury and Intended Context of Use. Diagnostics (Basel). 2016 Oct 18;6(4):37. doi: 10.3390/diagnostics6040037.
22. Wang KK, Yang Z, Zhu T, Shi Y, Rubenstein R, Tyndall JA, Manley GT. An update on diagnostic and prognostic biomarkers for traumatic brain injury. Expert Rev Mol Diagn. 2018 Feb;18(2):165-180. doi: 10.1080/14737159.2018.1428089.
23. Gan ZS, Stein SC, Swanson R, Guan S, Garcia L, Mehta D, Smith DH. Blood Biomarkers for Traumatic Brain Injury: A Quantitative Assessment of Diagnostic and Prognostic Accuracy. Front Neurol. 2019 Apr 26;10:446. doi: 10.3389/fneur.2019.00446.
Facebook 
Masuk dengan Email
